IB
ILIAD BIOTECHNOLOGIES, INC.
SEC filingBiotechnology · Weston, FL
Amount raised$115.5Msold at filing
Total offering$115.5M
Investors in the raise36count reported to the SEC
FiledFeb 20, 2026first sale Feb 5, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
William SteinkraussExecutive Officer
Avi NaiderDirector
Mario BarroDirector
Eric EdidinDirector
Keith RubinExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.